Aug 6, 2026 06:30AM
Jun 17, 2026 05:30PM
Jun 17, 2026 05:30PM
May 7, 2026 06:30AM
Mar 19, 2026 07:30AM
Dec 18, 2025 07:30AM
Nov 6, 2025 07:30AM Knight Therapeutics Reports Third Quarter 2025 Results
Oct 31, 2025 05:15PM
Oct 31, 2025 05:15PM
Sep 26, 2025 09:18AM
Aug 7, 2025 07:30AM
Jun 17, 2025 09:11AM
Jun 17, 2025 08:00AM
Jun 5, 2025 06:45AM Knight Therapeutics and Sumitomo Pharma enter into Exclusive Licensing Agreements to commercialize Sumitomo’s Canadian Portfolio
May 8, 2025 07:30AM
Mar 20, 2025 07:30AM
Mar 11, 2025 06:45AM
Nov 7, 2024 07:30AM
Aug 8, 2024 07:30AM
May 9, 2024 07:30AM
Mar 21, 2024 07:30AM Knight Therapeutics Reports Fourth Quarter and Year-End 2023 Results
Feb 28, 2024 07:30AM
Nov 9, 2023 07:30AM
Aug 10, 2023 07:30AM
May 11, 2023 07:30AM
May 9, 2023 05:09PM
Mar 23, 2023 07:30AM
Nov 10, 2022 07:30AM Knight Therapeutics Reports Third Quarter 2022 Results
Aug 15, 2022 07:30AM
Aug 11, 2022 07:30AM
Jun 1, 2022 07:30AM
May 12, 2022 07:30AM
Mar 24, 2022 07:30AM
Nov 11, 2021 07:30AM
Aug 13, 2021 07:30AM Knight Therapeutics Reports Second Quarter 2021
May 26, 2021 05:10PM
May 25, 2021 05:30PM
May 14, 2021 07:30AM
May 13, 2021 09:50PM
May 13, 2021 09:23AM
May 12, 2021 07:59PM
May 7, 2021 07:30AM Avis de conférence téléphonique de Thérapeutique Knight sur ses résultats du premier trimestre 2021
Apr 23, 2021 07:30AM
Apr 13, 2021 05:44PM
Mar 25, 2021 07:30AM
Mar 18, 2021 07:30AM
Mar 1, 2021 07:04PM
Dec 23, 2020 06:08PM
Dec 10, 2020 02:40PM Knight Announces Filing of Preliminary Base Shelf Prospectus
Nov 13, 2020 07:30AM

1,180,926 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All